Disease name and definition
Malignant mesothelioma is a fatal
asbestos-associated malignancy originating from
the lining cells (mesothelium) of the pleural and peritoneal
cavities, as well as
the pericardium and the tunica vaginalis. The exact prevalence
is unknown but it is
estimated that mesotheliomas represent less than 1% of all
cancers. Its incidence
is increasing, with an expected peak in the next 10–20 years.
Pleural malignant mesothelioma
is the most common form of mesothelioma. Typical presenting
features are those of
chest pain and dyspnoea. Breathlessness due to a pleural
effusion without chest pain
is reported in about 30% of patients. A chest wall mass, weight
loss, sweating, abdominal
pain and ascites (due to peritoneal involvement) are less
common presentations. Mesothelioma
is directly attributable to occupational asbestos exposure with
a history of exposure
in over 90% of cases. There is also evidence that mesothelioma
may result from both
para-occupational exposure and non-occupational "environmental"
exposure. Idiopathic
or spontaneous mesothelioma can also occur in the absence of
any exposure to asbestos,
with a spontaneous rate in humans of around one per million. A
combination of accurate
exposure history, along with examination radiology and
pathology are essential to
make the diagnosis. Distinguishing malignant from benign
pleural disease can be challenging.
The most helpful CT findings suggesting malignant pleural
disease are 1) a circumferential
pleural rind, 2) nodular pleural thickening, 3) pleural
thickening of > 1 cm and 4)
mediastinal pleural involvement. Involvement of a
multidisciplinary team is recommended
to ensure prompt and appropriate management, using a framework
of radiotherapy, chemotherapy,
surgery and symptom palliation with end of life care.
Compensation issues must also
be considered. Life expectancy in malignant mesothelioma is
poor, with a median survival
of about one year following diagnosis.

0 comments:
Post a Comment